Colorectal Cancer Clinical Trials in North Carolina

Showing 41-60 of 263 trials

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

NCT05520099

The primary objective of this study is to develop and train the Elephas live tumor diagnostic platform and determine the ex-vivo accuracy of the Elephas Score using in-vivo RECIST 1.1 as the reference method

ImmunotherapyCancerBladder Cancer+16 more

Elephas416 participantsStarted Jun 2023

Little Rock, Arkansas, United States • Salinas, California, United States • Orlando, Florida, United States +9 more locations

COMPLETED46 miles

Prevention of Colorectal Cancer Through Multiomics Blood Testing

NCT04369053

The PREEMPT CRC study is a prospective multi-center observational study to validate a blood-based test for the early detection of colorectal cancer by collecting blood samples from average-risk participants who will undergo a routine screening colonoscopy.

Colon CancerRectal CancerColon Neoplasm+8 more

Freenome Holdings Inc.48,995 participantsStarted May 2020

Birmingham, Alabama, United States • Birmingham, Alabama, United States • Huntsville, Alabama, United States +145 more locations

Observational Basket Trial to Collect Tissue to Develop and Train a Live Tumor Diagnostic Platform

Prevention of Colorectal Cancer Through Multiomics Blood Testing

Colorectal Cancer Trials in Other Cities

A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors

A Phase 1 in Patients With HLA-A*0201+ and WT1+ Recurrent/Metastatic Cancers

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Testing the Use of BRAF-Targeted Therapy After Surgery and Usual Chemotherapy for BRAF-Mutated Colon Cancer

A Clinical Study of MK-2870 Alone or With Other Treatments to Treat Gastrointestinal Cancers (MK-9999-02A)

Study of DECOY20 With or Without Tislelizumab in Patients With Advanced Solid Tumors

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Radiation Therapy and Fluorouracil With or Without Combination Chemotherapy Followed by Surgery in Treating Patients With Stage II or Stage III Rectal Cancer

EXoPERT EMERALD Clinical Study

ASPIRES (Activating Cancer Survivors and Their Primary Care Providers to Increase Colorectal Cancer Screening) Study

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers

A Study of Select Drug Combinations in Adult Patients With Advanced/Metastatic BRAF V600 Colorectal Cancer

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

Community Collaboration to Advance Racial/Ethnic Equity in CRC Screening

Early Onset Colorectal Cancer Detection

Other Conditions in North Carolina